The 4th International Cancer Immunotherapy kicks-off in New York City

The CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference started today with a three and a half day program featuring talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism. The conference can be followed on Twitter #CICON18